Literature DB >> 8011283

Assembly, transport, and function of MHC class II molecules.

P Cresswell1.   

Abstract

MHC class II molecules assemble in the endoplasmic reticulum in a chaperone-mediated fashion to form a nine-chain structure consisting of three alpha beta dimers associated with an invariant chain trimer. This complex is transported through the Golgi apparatus and into the endosomal system. The signal for endosomal targeting resides in the cytoplasmic tail of the invariant chain. Current evidence argues that the segregation of the class II-invariant chain complex from the constitutive pathway of membrane protein transport occurs in the trans-Golgi network. However, class II-invariant chain complexes that reach the cell surface are also rapidly internalized into endosomes. Within the endosomal system, probably in a late endosome/pre-lysosome, the invariant chain is degraded, releasing alpha beta dimers that bind peptides predominantly derived from endocytosed proteins. Evidence suggests that many of these peptides are actually generated in lysosomes. The precise mechanisms involved in forming class II-peptide complexes are unclear, although the existence of antigen-processing mutants argues that additional gene products, at least one of which is encoded in the MHC, are involved. After binding peptides, class II molecules are transported by an unknown route to the cell surface, where their primary function of presenting antigenic peptides to CD4+ T cells is carried out.

Mesh:

Substances:

Year:  1994        PMID: 8011283     DOI: 10.1146/annurev.iy.12.040194.001355

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  218 in total

1.  Early endosomes are required for major histocompatiblity complex class II transport to peptide-loading compartments.

Authors:  V Brachet; G Péhau-Arnaudet; C Desaymard; G Raposo; S Amigorena
Journal:  Mol Biol Cell       Date:  1999-09       Impact factor: 4.138

2.  Early endosomal maturation of MHC class II molecules independently of cysteine proteases and H-2DM.

Authors:  J A Villadangos; C Driessen; G P Shi; H A Chapman; H L Ploegh
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

Review 3.  Mechanisms of immune escape in viral hepatitis.

Authors:  W Rosenberg
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

4.  Surface-expressed invariant chain (CD74) is required for internalization of human leucocyte antigen-DR molecules to early endosomal compartments.

Authors:  G Moldenhauer; C Henne; J Karhausen; P Möller
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

5.  Kinetics and intracellular pathways required for major histocompatibility complex II-peptide loading and surface expression of a fluorescent hapten-protein conjugate in murine macrophage.

Authors:  D J Weaver; E W Voss
Journal:  Immunology       Date:  1999-04       Impact factor: 7.397

6.  Invariant chain induces B cell maturation in a process that is independent of its chaperonic activity.

Authors:  Didi Matza; Frida Lantner; Yoel Bogoch; Liat Flaishon; Rami Hershkoviz; Idit Shachar
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

7.  Expression of the three human major histocompatibility complex class II isotypes exhibits a differential dependence on the transcription factor RFXAP.

Authors:  M Peretti; J Villard; E Barras; M Zufferey; W Reith
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

8.  Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II.

Authors:  Wojciech Wiszniewski; Marie-Claude Fondaneche; Pascale Louise-Plence; Ada Prochnicka-Chalufour; Françoise Selz; Cappucine Picard; Françoise Le Deist; Jean-François Eliaou; Alain Fischer; Barbara Lisowska-Grospierre
Journal:  Immunogenetics       Date:  2003-01-16       Impact factor: 2.846

9.  Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma.

Authors:  Sarah T Wilkinson; Kristie A Vanpatten; Diane R Fernandez; Patrick Brunhoeber; Karl E Garsha; Betty J Glinsmann-Gibson; Thomas M Grogan; Julie Teruya-Feldstein; Lisa M Rimsza
Journal:  Blood       Date:  2011-12-13       Impact factor: 22.113

Review 10.  Novel mechanisms of class II major histocompatibility complex gene regulation.

Authors:  Michael Radosevich; Santa Jeremy Ono
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.